These findings suggest that CCK+/CB1R+ interneuron axon targeting defects may contribute to cognitive impairments and seizure susceptibility in dystroglycanopathy. The gene discussed is CNR1; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.